Mark G Trombetta, MD

Moses S. Raj, MD, is a medical oncologist with AHN Cancer Institute, specializing in providing compassionate and empathetic oncological care, with a focus on lung cancer. He has expertise in treating gastrointestinal, pancreatic, and hepatobiliary malignancies. Dr. Raj went to medical school at Guntur Medical College in Guntur, India. He did his residency at Metrowest Medical Center in Framingham, Massachusetts and did his fellowship in hematology and oncology at University of Iowa Hospitals in Iowa City, Iowa. Dr. Raj is certified by the American Board of Internal Medicine in Medical Oncology and Hematology and is affiliated with the American Society of Clinical Oncology. He sees patients ages 18 and older.

Adam L. Johnson, MD, is a general surgeon, specializing in breast surgical oncology. His expertise encompasses a wide range of surgical procedures, and he is dedicated to providing compassionate, high-quality surgical care. His clinical experience includes minimally invasive techniques for patients with breast disease. Dr. Johnson went to medical School at Boston University School of Medicine. He completed his general surgery residency at Menorah Medical Center in Overland Park, Kansas, and fellowship in breast surgical oncology at Allegheny Health Network. Dr. Johnson is a member of the Allegheny County Breast Consortium. He has a focus on enriching the community with outreach to promote breast cancer awareness. Dr. Johnson welcomes patients ages 18 and older.

Nathan Bahary MD, PhD received his B.A. from Cornell University, an M.D. from the Cornell University School of Medicine, and his Ph.D. from the Rockefeller University. He completed his residency at Beth Israel Hospital in Boston. He did his postgraduate training at the Dana Farber Cancer Institute, Harvard, and Brigham and Women’s Hospital system before joining the faculty of UPMC as the Director of the Pancreatic Cancer Center. Since 2021, he is the Division Chief of Medical Oncology at AHN Cancer Institute and Director of AHNCI Clnical Research. Amongst his various appointments Dr. Bahary is a member of the NCI Pancreatic Task Force, the Eastern Cooperative Oncology Group (ECOG) where he serves on the ECOG GI Steering Committee and the American Society of Clinical Oncology (ASCO) His basic research interests lie in the intersection between gastrointestinal development, metabolic stress pathways, immunology, and cancer. He has a broad research background in cancer genetics, developmental biology, molecular biology, and clinical investigations, with specific training and expertise in key research areas broadly within the field of gastrointestinal oncology, and specifically within pancreatic cancer. Building on his work at Harvard Medical School, Dr. Bahary is using insights gained by studying vertebrate development to determine how cancers grow. Clinical trials emanating from this research will continue at AHN Cancer Institute and are expected to lead to the development of new targeted agents and immunologic strategies for treating cancer.